UBS raised its target price for Oracle (NASDAQ:ORCL) to $39 from $36 and reiterated its buy rating on the company, after the company reported better than expected earnings yesterday afternoon and boosted its dividend. The bank also said Oracle showed accelerating license growth as well as exadata and exalogic sales, and expects no material impact from the crisis in Japan. UBS raised its fiscal year 2012 EPS estimate to $2.35 from $2.28, vs. the consensus estimate for $2.31 per share. Oracle has a potential upside of 12% based on a current price of $32.14 and an average consensus analyst price target of $36.
